Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Combining Zephyr and Spiration valve therapy benefited patients with COPD and advanced pulmonary emphysema while imparting a ...

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

Exacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Sponsor:  Consultancy Media for Sanofi and Regeneron In the state of Ohio alone, more than 800,000 people are living with COPD. It’s a chronic lung disease that limits air flow and ...

The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well ...

A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...

Several features of COPD (dyspnea, air hunger, functional decline, and the possibility of mechanical ventilation) commonly force patients and physicians to confront end-of-life issues. Chronic ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...